[Treatment adherence in inflammatory bowel disease. Strategies for improvement]

Since inflammatory bowel disease (IBD) is a chronic condition that frequently affects young patients, requires prolonged therapy and is characterized by periods of clinical remission, there is a risk of low treatment adherence. Adherence is influenced by several factors: disease and patient characteristics, treatment complexity and the physician-patient relationship. Given the importance of adherence in treatment results, lack of adherence should be detected and treated. To do this, systematic surveillance can be performed in consultations or can be centered on non-responders or patients with risk factors for lack of adherence. Elements that help to achieve good treatment adherence are a good physician-patient relationship and specific actions, such as optimizing the information provided to patients on their disease and dosage adjustments taking the patient's opinion into consideration.